标普料诺亚控股诉讼风险上升展望下调至“负面”
标准普尔发表报告表示,将诺亚控股展望调整至“负面”,同时确认长期主体评级“BBB-”,以反映该公司的资产管理规模及相关管理费收入可能受到公司投资在承兴国际控股(2662.HK)的信贷基金事件的影响,并认为诺亚控股的诉讼风险已上升。
标普预计,诺亚不会兜底受承兴影响的34亿元(人民币,下同)产品,其相关供应链融资的资管敞口约占其信贷基金的9%和总资产管理规模的2%。相较自2016年开始的累积峰值约100亿元产品发行,该敞口已缩小。该机构又预计诺亚将放慢发行甚至缩减其私募信贷投资产品,而承兴相关产品料影响了约4%目前在诺亚有投资的客户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.